ITOS - iTeos Therapeutics Inc. (ITOS) CEO Michel Detheux on Q3 2021 Results - Earnings Call Transcript

iTeos Therapeutics Inc. (ITOS) Q3 2021 Earnings Conference Call November 10, 2021 04:30 PM ET Company Participants Ryan Baker - Head-IR Michel Detheux - President and CEO Matthew Gall - CFO Joe Lager - CMO Conference Call Participants Daina Graybosch - SVB Leerink Anupam Rama - JP Morgan David Nierengarten - Wedbush Securities Swayampakula Ramakanth - H.C. Wainwright Presentation Operator Good afternoon and welcome to the iTeos Therapeutics’ Third Quarter 2021 Financial Results Conference Call. This time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company’s request. At this time I would like to turn it over to Ryan Baker, Head of Investor Relations at iTeos. Ryan please proceed. Ryan Baker Thank you Operator and thank you everyone on the call for joining us today. Joining me

For further details see:

iTeos Therapeutics Inc. (ITOS) CEO Michel Detheux on Q3 2021 Results - Earnings Call Transcript